Salvina Therapeutics Company
Salvina Therapeutics is working to break through efficacy barriers in inflammatory and autoimmune illnesses. The business discovered a novel epitope for specifically targeting TNF, culminating in the development of antibodies with a novel mode of action.
Employee Number:
1-10
Headquarters:
Allschwil, Basel-Landschaft, Switzerland, Europe
Founded Date:
2023-05-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
BaseLaunch
Ipo Status:
private
City:
Allschwil
Region:
Basel-Landschaft
Country:
Switzerland